http://web.archive.org/web/20090312004204id_/http://www.cnn.com:80/2009/BUSINESS/03/09/merck.schering.plough.merger/index.html

-- pharmaceuticals giants @entity2 and @entity3 are planning to merge their operations under the name @entity2 in a deal worth $ 41.1 billion			2
@entity2 chairman and ceo @entity7 will head the combined company			2
under the terms of the agreement , @entity3 shareholders will receive just over half a @entity2 share and $ 10.50 in cash for each @entity3 share they own			1
each @entity2 share will automatically become a share of the combined company			1
@entity2 shareholders are expected to own approximately 68 percent of the combined company , and @entity3 shareholders are expected to own approximately 32 percent			1
@entity2 chairman , president and chief executive officer @entity7 will lead the combined company			2
" we are creating a strong , global healthcare leader built for sustainable growth and success , " @entity7 said in a media statement monday			0
" the combined company will benefit from a formidable research and development pipeline , a significantly broader portfolio of medicines and an expanded presence in key international markets , particularly in high - growth emerging markets			0
" we look forward to joining forces with an outstanding partner we know well and that shares our commitment to patients , employees and the communities where we work and live			0
" @entity2 added that its 2009 outlook has not changed , and it is committed to keeping its annual dividend at its current level of $ 1.52 per share			0
both drug - makers reported better - than - expected quarterly results in early february , but announced steep job cuts			1
on a conference call with investors on february 3 , @entity7 said the drug - maker was open to a takeover of a large pharmaceutical company .			0

@entity3 shareholders to get over half a @entity2 share and $ 10.50 in cash per share
@entity2 shareholders expected to own around 68 percent of combined company
both drug - makers reported better - than - expected quarterly results in february

@entity3:SP
@entity2:Merck
@entity0:CNN
@entity7:Clark